DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.

Br J Cancer · 1996 · PMC2074828 · PMID 8980401

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, 20q13 amplification showed a trend of association with stage 3, and MDM2 amplification seemed restricted to serous adenocarcinoma.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.